New association studies with larger sample sizes and more comprehensive information about patients’ lifestyles are needed to clarify the association of ESR1 polymorphisms and synonymous mutations with breast cancer development to determine whether they are a relevant risk or prognostic factors. The gene discussed is ESR1; the disease is breast cancer.